Astera Labs, Inc. Common Stock (ALAB) Stock: Price, Forecast & Analyst Target
Astera Labs, Inc. Common Stock (ALAB) — MoonshotScore 87/100 (Exceptional band), calculated Nov 18, 2026. Price $216.75 (+2.43%), as of the Nov 18, 2026 trading session; market cap $37.9B.
Educational signal · not a buy or sell recommendation · How to read this
Astera Labs, Inc. Common Stock · ALAB · NASDAQ · Technology · Semiconductors
Research dated 2026-09-13: Astera Labs supplies semiconductor-based data, network and memory connectivity for cloud and artificial intelligence systems; it enables processors and memory to communicate rather than selling the processors that perform the computing. Scorpio’s ramp now has to sustain rapid revenue and profit expansion while the guided gross margin softens and the valuation assumes substantial future growth.
Price as of Nov 18, 2026
Key Statistics
MoonshotScore v2 · Astera Labs, Inc. Common Stock (ALAB)
ExceptionalWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
Elite quality, a strong balance sheet and elite growth, but an expensive valuation. Business Quality: Elite; Financial Safety: Fortress; Valuation: Bubble; Growth Durability: Compounding; Momentum: Quiet.
Enterprise value relative to free cash flow is the main valuation drag relative to sector peers.
- EPS beat 0 of the last 4 reports
- Altman Z 74.69 · Piotroski F 5
- ROE 28.2% · ROA 13.4% · current ratio 8.03
Holding back: a rich price
Helping: business quality, balance-sheet strength, durable growth
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 82 | Exceptional | |
| 82 | Exceptional | |
| 81 | Exceptional | |
| 81 | Exceptional | |
| 87 | Exceptional | |
| 87 | Exceptional |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $216.75 | |
| Change on the day | +2.43% | |
| 52-week range | $97.89–$499.48 | |
| Market capitalisation | $37.9B | — |
| Price / earnings (trailing) | 78.96 | |
| Shares traded on the day | 4.57M | |
| Beta (volatility vs the S&P 500) | 3.86 |
Why Astera Labs, Inc. Common Stock scores 87
Share price, last 12 months +24.8%
$173.74 $216.87
What the price assumes
30.4% a year of free-cash-flow growth for ten years is what a $37.62B market value ( snapshot) asks for.
The price asks for less growth than the business has been producing. The question it leaves open is how long that pace lasts, not whether it exists.
Reverse discounted cash flow: 10% discount rate, 3% growth after year ten, starting from trailing twelve months free cash flow of $344.69M. Inputs: FMP statements, estimates and quote.
How the stock reacts to earnings
EPS beat in 11 of the last 12 reports (2024–2026); the stock still fell the next session after 8 of those beats. Average first-session move: 12.4% either way.
- +12.8%Mar ’24
- -11.3%May ’24
- -16.9%Aug ’24
- +32.0%Nov ’24
- -9.1%Feb ’25
- -1.5%May ’25
- +26.4%Aug ’25
- -5.0%Nov ’25
- -23.4%Feb ’26
- +6.3%May ’26
- -0.8%Aug ’26
- -2.8%Nov ’26
Every report, with revenue and five-session moves
| Report | EPS | Revenue | Next session | 5 sessions |
|---|---|---|---|---|
| Beat | Beat | -2.8% | — | |
| Beat | Beat | -0.8% | -2.8% | |
| Beat | Beat | +6.3% | +1.6% | |
| Beat | Beat | -23.4% | -31.0% | |
| Beat | Beat | -5.0% | -12.5% | |
| Beat | Beat | +26.4% | +39.2% | |
| Beat | Beat | -1.5% | +21.6% | |
| Beat | Miss | -9.1% | -7.9% | |
| Beat | Beat | +32.0% | +27.0% | |
| Beat | Miss | -16.9% | -7.7% | |
| Beat | Beat | -11.3% | -7.4% | |
| — | — | +12.8% | +19.6% |
Beating the estimate has not been enough: the stock fell after 8 of the last 11 beats. The bar it has to clear is the whisper number, not the published one.
What management is saying differently
Management's own words on the Q3 FY2026 call () against Q2 FY2026 (). Analysts' questions are left out.
- New this call: “memory solutions”, “pcie gen”, “rack scale”, “growth opportunities” — none of them came up in Q2 FY2026.
- Getting louder: “revenue growth” (3 → 6 mentions), “memory controllers” (2 → 5 mentions), “addressable market” (1 → 4 mentions).
- Gone quiet: “volume production”, “gross margins”, “cosmos platform” — regular themes last call, absent this time.
The tone held steady from one call to the next; what changed is the subject matter, not the confidence.
Our track record on this stock
Since the score went from 87 to 87 while the share price moved -21.9% through .
| Date | Band | 3 months | 6 months | Call |
|---|---|---|---|---|
| Strong → Exceptional | — | — | — | |
| Exceptional → Strong | — | — | — | |
| Strong → Exceptional | — | — | — | |
| Exceptional → Strong | — | — | — | |
| Strong → Exceptional | — | — | — | |
| Exceptional → Strong | — | — | — |
None of the 10 band changes we have recorded has been graded yet; we grade each band change three months after it happens.
The crowd against our signals
- Analysts: 72% of 18 rate it a buy; the average target sits +67.6% from the price of $216.75.
- Last 90 days: 1 upgrade and 0 downgrades among 9 rating actions.
- Our signals: Exceptional band; strongest pillar Growth Durability (98), weakest Valuation (19).
Here we and the crowd agree. Where we differ is on price: our Valuation reading is more cautious than the analysts' targets.
Price & events
Point at or tab to any week for its close.
Other perspectives
Council score for Astera Labs, Inc. Common Stock (ALAB): perspectives
Some lenses disagree with the MoonshotScore. Compare their readings below; each uses a different method.
5-Factor Breakdown
Legends Council
6 lenses, 6 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 20, 2026
Munger's Mindset
Balance Sheet & Valuation
Read on: Nov 19, 2026
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
Two of these lenses read this company less favourably than the MoonshotScore does: Simons-style lens and Klarman-style lens. Each lens is a separate scoring function over its own inputs, so a disagreement is a difference of method rather than a correction — the page's answer stays the MoonshotScore above.
The Munger lens reads the current price as fairly valued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is Astera Labs, Inc. Common Stock (ALAB), and what does it report?
Short answer · as of
Astera sells connectivity products unified by a software-defined architecture, with demand tied to the deployment and scaling of cloud and artificial intelligence infrastructure.
Research dated 2026-09-13.
Its economic role is moving data among compute, network and memory resources, which differs from the processor exposure commonly associated with semiconductor companies.
Reported revenue is consolidated into a reportable segment, so the accounts show platform-wide sales without revealing revenue by product family. The annual and quarterly series therefore measure the expansion of the overall connectivity franchise, not the separate contribution of Scorpio, Leo or other product lines.
What do the latest results show for Astera Labs, Inc. Common Stock (ALAB)?
Research dated 2026-09-13.
The latest results extended a steep sequential expansion: revenue, gross profit, operating profit, net income and diluted earnings per share all advanced. Operating cash flow also remained positive, while research and development spending climbed as Astera funded its product roadmap. The release continued a run in which reported revenue and earnings surpassed market expectations.
Management attributed the next phase to Scorpio X-Series volume production and expects the Scorpio family to become the largest product category by revenue. Its outlook calls for another sizable revenue step-up but a lower gross margin than the latest reported level, making product mix and ramp economics as important as headline growth.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Sep 30, 2026 | Not available | Not available | Not available | Not available |
| Jun 30, 2026 | Not available | Not available | Not available | Not available |
| Mar 31, 2026 | Not available | Not available | Not available | Not available |
| Dec 31, 2025 | Not available | Not available | Not available | Not available |
How to read these figures
Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Sep 2025 | $231M | $91M | $0.50 (diluted) |
| Q4 FY2025 | $271M | $45M | $0.25 (diluted) |
| Q1 FY2026 | $308M | $80M | $0.44 (diluted) |
| Q2 FY2026 | $392M | $153M | $0.83 (diluted) |
What are the financial strengths and risks for Astera Labs, Inc. Common Stock (ALAB)?
Short answer
Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway.
Research dated 2026-09-13.
Astera carries no debt, holds a large cash and short-term investment balance, and has increased that balance across the reported history. Operating cash flow has stayed positive, with capital spending remaining below operating cash generation, giving the company room to support rising research and development expenditure without balance-sheet strain.
The equity valuation is far less forgiving than the finances: market value stands far above net cash, while earnings and free-cash-flow yields remain thin. A slowdown in cloud and artificial intelligence infrastructure deployment, disappointing Scorpio adoption, or continued gross-margin compression could expose how much growth is embedded in that valuation.
Data-derived red flags
- Inconsistent delivery — missed Wall Street EPS estimates in 0 of the last 4 reported quarters.
- Rich valuation — a P/E of 78.96 runs well above the Technology sector’s ~28.90x, leaving little room for a miss.
What should you watch next at Astera Labs, Inc. Common Stock (ALAB)?
Short answer · as of
Current published price targets run low $275.00 · high $500.00 · consensus $363.36 · median $325.00 against a quoted price of $216.75 (as of Nov 18, 2026).
Research dated 2026-09-13.
Scorpio’s promised transition into Astera’s largest product category is the most concrete product-mix checkpoint. Readers should compare reported revenue with management’s outlook, then examine whether the expected gross-margin decline is temporary mix pressure or persists as volume expands.
Research and development is rising quickly, so operating leverage and cash conversion deserve attention alongside sales. Farther out, volume shipments of standard and custom Leo CXL memory controllers to U.S. hyperscalers would demonstrate that Astera can extend its connectivity platform across general-purpose computing and artificial intelligence inference; the wide range of longer-horizon revenue estimates reinforces the need for product evidence.
What the records here don't tell us
- No forward revenue or earnings estimate is on file.
- The next earnings date is not yet scheduled in the calendar we read.
Checked against the records this page reads, on the dates shown above.
How does Astera Labs, Inc. Common Stock compare with its peers?
Short answer
Astera Labs, Inc. Common Stock's score ranks 3rd of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
Research dated 2026-09-13.
Processor vendors monetize the engines performing computation; Astera monetizes the links joining compute, network and memory resources. Its products share a software-defined architecture, giving customers a connectivity platform rather than an isolated chip function.
Astera also reports its operations as a consolidated segment, unlike diversified semiconductor businesses whose segment accounts expose separate end markets. That makes product milestones such as Scorpio becoming the largest revenue category and Leo entering hyperscaler volume production unusually important for interpreting the mix.
| Company | Price | Market value | Score |
|---|---|---|---|
| $776.22 Nov 18, 2026 | $110B | 99 5-pillar Nov 18, 2026 | |
| $235.21 Nov 18, 2026 | $36.7B | 91 5-pillar Nov 18, 2026 | |
| Astera Labs, Inc. Common Stock (ALAB) — this page | $216.75 | $37.9B | 87 |
| $1310.91 Nov 18, 2026 | $63.9B | 82 5-pillar Nov 18, 2026 | |
| $13.96 Nov 18, 2026 | $35.0B | 81 5-pillar Nov 18, 2026 | |
| $32.53 Nov 18, 2026 | $71.8B | 77 5-pillar Nov 18, 2026 | |
| $286.30 Nov 18, 2026 | $48.7B | 77 5-pillar Nov 18, 2026 | |
| $252.47 Nov 18, 2026 | $63.6B | 77 5-pillar Nov 18, 2026 | |
| $143.78 Nov 18, 2026 | $22.0B | 67 5-pillar Nov 18, 2026 | |
| $45.78 Nov 18, 2026 | $60.8B | 65 5-pillar Nov 18, 2026 | |
| $44.91 Nov 18, 2026 | $40.1B | 65 5-pillar Nov 18, 2026 | |
| $67.23 Nov 18, 2026 | $26.2B | 65 5-pillar Nov 18, 2026 | |
| $59.67 Nov 18, 2026 | $32.5B | 61 5-pillar Nov 18, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $275.00 – $500.00
- Consensus target
- $363.36
- Median target
- $325.00
Consensus record · Captured .
Measured against a quoted price of $216.75 (as of Nov 18, 2026).
Insider activity
Form 4 records via FMP · Of the newest 500 records, those within the last 180 days, newest dated Nov 5, 2026
- Transactions
- 221
- Identified insiders
- 10
- Purchases
- 0
- Sales
- 212
- Other transactions
- 9
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held ALAB in their latest 13F filing, and what they did against the filing before it.
None of the 16 tracked investors reported ALAB in their latest 13F filing.
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Common Questions About ALAB (Technology)
Research dated 2026-09-13; the full attribution is under Sources. The last 2 questions are answered from this page's own dated data, not from the research.
Why can Astera Labs grow without selling artificial intelligence processors?
Artificial intelligence systems require data to move among processors, memory and networks, and Astera sells the semiconductor-based connectivity that supports those paths. Its demand therefore rises with the scale and complexity of deployed infrastructure, even though it does not sell the compute engines themselves.
What would make Scorpio X-Series important to Astera Labs?
Reaching that milestone would confirm a material shift in product mix during a period of rapid company-wide growth.
Where do Leo CXL memory controllers fit in Astera Labs?
Leo extends Astera’s platform into memory connectivity for general-purpose computing and artificial intelligence inference. Management expects standard and custom controllers to ship in volume to U.S. hyperscalers, making customer deployment the relevant proof point.
Can Astera Labs fund its connectivity roadmap from its own balance sheet?
The company has substantial cash and short-term investments, no debt and positive operating cash generation across the reported period. That capacity supports rising research and development spending, though sustained cash conversion remains important as product investment and capital spending increase.
What is the ALAB stock price today?
The last price recorded for Astera Labs, Inc. Common Stock (ALAB), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the ALAB price target?
The analyst consensus price target for Astera Labs, Inc. Common Stock (ALAB), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
Research written by Codex (gpt-5.6-sol) on 2026-09-13. AI-authored analysis; source dates are listed under Sources. Reviewed by Sedat ANAK, Founder and Editor-in-Chief, on 2026-11-07.
Sources: the source register lists the 26 figures on this page — 1 from SEC filings and earnings calls, 20 from Financial Modeling Prep (FMP), 3 with no recorded source and 2 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
